[{"Assets_0_FY_USD":717802000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":0.0,"CommonStockSharesConverted_0_FY_shares":124267358.0,"CommonStockSharesOutstanding_0_FY_shares":124267358.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-137350000.0,"NetIncomeLossConverted_8_FY_USD":-396100000.0,"NetIncomeLossConverted_4_FY_USD":-184594000.0,"NetIncomeLossConverted_1_FY_USD":-61030000.0,"StockholdersEquity_0_FY_USD":629023000.0,"EarningsPerShareBasic_4_FY_USD":-1.83,"EarningsPerShareBasic_1_FY_USD":-0.58,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200227"}]